Acorah Software Products - Accounts Production 16.7.461 false true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 11274944 S Pathak U Pathak S Pathak false iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11274944 2024-03-31 11274944 2025-03-31 11274944 2024-04-01 2025-03-31 11274944 frs-core:CurrentFinancialInstruments 2025-03-31 11274944 frs-core:ShareCapital 2025-03-31 11274944 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 11274944 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 11274944 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 11274944 frs-bus:SmallEntities 2024-04-01 2025-03-31 11274944 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 11274944 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 11274944 1 2024-04-01 2025-03-31 11274944 frs-bus:Director1 2024-04-01 2025-03-31 11274944 frs-bus:Director2 2024-04-01 2025-03-31 11274944 frs-countries:EnglandWales 2024-04-01 2025-03-31 11274944 2023-03-31 11274944 2024-03-31 11274944 2023-04-01 2024-03-31 11274944 frs-core:CurrentFinancialInstruments 2024-03-31 11274944 frs-core:ShareCapital 2024-03-31 11274944 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Registered number: 11274944
Teeta Pharma Consulting Limited
Unaudited Financial Statements
For The Year Ended 31 March 2025
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 11274944
2025 2024
Notes £ £ £ £
CURRENT ASSETS
Cash at bank and in hand 89 82
89 82
Creditors: Amounts Falling Due Within One Year 4 (2,428 ) (1,783 )
NET CURRENT ASSETS (LIABILITIES) (2,339 ) (1,701 )
TOTAL ASSETS LESS CURRENT LIABILITIES (2,339 ) (1,701 )
NET LIABILITIES (2,339 ) (1,701 )
CAPITAL AND RESERVES
Called up share capital 100 100
Profit and Loss Account (2,439 ) (1,801 )
SHAREHOLDERS' FUNDS (2,339) (1,701)
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
S Pathak
Director
8th December 2025
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Teeta Pharma Consulting Limited is a private company, limited by shares, incorporated in England & Wales, registered number 11274944 . The registered office is Unit 4a, Langley House, Wheatcroft Business Park, Landmere Lane, Edwalton, Nottingham, NG12 4DG.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
4. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Other creditors 2,428 1,783
5. Related Party Transactions
As at the 31st March 2025 the company owed the directors £1,984 (2024: £1,363).
6. Controlling Party
The company's controlling party is S Pathak by virtue of his ownership of 90% of the issued share capital in the company.
Page 2